Evidence map›Paper›PMID 42624601›Full record

ArticleBMJ open2026

How were pregnant women included in emergency COVID-19 vaccine delivery in The Gambia? A qualitative study of perspectives of healthcare workers and policy influencers.

Oluwatosin Nkereuwem, Alpha Omar Jallow, Alero Ogbebor, James Owolabi, Musa Marena, Sidat Fofanna, Joanna Busza, Uduak Okomo, Beate Kampmann

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Oluwatosin NkereuwemVaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia oluwatosin.nkereuwem@lshtm.ac.uk.ORCID 0000-0001-6194-6228
Alpha Omar JallowVaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Alero OgbeborVaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
James OwolabiVaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Musa MarenaReproductive, Maternal, Newborn Child and Adolescent Health Programme (RMNCAH), Ministry of Health, Kanifing, Gambia.
Sidat FofannaExpanded Programme on Immunization, Ministry of Health, Kotu, Gambia.
Joanna Busza *London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy, London, UK.
Uduak Okomo *Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Beate Kampmann *Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Funding

UK Biotechnology and Biological Sciences Research Council MR/R005990/1UK Medical Research Council MR/R005990/1
6 · The paper itself

Abstract

objectivesPregnant women are at increased risk of severe illness and adverse pregnancy outcomes during infectious disease outbreaks, yet they are frequently excluded from early emergency vaccine responses. During the COVID-19 pandemic, evolving pregnancy-specific safety evidence contributed to delayed and inconsistent guidance, complicating integration of vaccination into routine maternal health services. This study examined how pregnant women were included in The Gambia's COVID-19 vaccine rollout and identified priorities to strengthen pregnancy-inclusive preparedness for future emergencies.

designWe conducted a qualitative exploratory study in The Gambia using semistructured key informant interviews with healthcare workers and policy influencers followed by facilitator-guided group discussions during a participatory workshop. Data were analysed using a hybrid deductive-inductive framework synthesis approach guided by the Consolidated Framework for Implementation Research (CFIR).

settingThe Gambia, within the Ministry of Health facilities and a national workshop venue. Data were collected between September 2023 and November 2024, following national expansion of COVID-19 vaccine eligibility to pregnant women in The Gambia.

participants15 key informants (healthcare workers and policy influencers involved in maternal health, immunisation and vaccine policy) and 29 participants in a subsequent participatory workshop.

resultsAcross CFIR domains, implementation was shaped by evolving safety and eligibility guidance, which reduced confidence in counselling and contributed to hesitancy. Outer-setting influences included misinformation and social influence within households and communities, alongside trust in ministry of health actors and endorsement by religious and traditional leaders. Inner-setting constraints included fragmented delivery pathways not integrated into antenatal care, transport and cold-chain challenges, and weak documentation and adverse event reporting that limited visible safety reassurance. At the individual level, healthcare workers were trusted but constrained by staffing pressures, long waiting times and limited access to timely information, while visible role-modelling supported acceptance. Suggested strategies included early training, cross-cadre coordination, strengthened logistics and data systems, improved safety monitoring and communication, and investment in workforce retention and sustainable financing.

conclusionsPregnancy-inclusive emergency vaccination requires coordinated action across guidance, community engagement, service organisation, workforce readiness and safety monitoring. Embedding these determinants within routine preparedness, rather than relying on ad hoc emergency responses, can improve equity and effectiveness globally.

Indexed as

COVID-19COVID-19 VaccinesHealth PersonnelPregnant PeopleAdultFemaleGambiaHumansMaternal Health ServicesPregnancyQualitative ResearchSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19Disease OutbreaksPregnancy

Identifiers

PMID42624601
PMCPMC13504901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.